Suppr超能文献

区域胰十二指肠切除术与标准胰十二指肠切除术联合门静脉切除治疗伴有门静脉侵犯的胰腺导管腺癌。

Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.

机构信息

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

出版信息

BJS Open. 2020 Jun;4(3):438-448. doi: 10.1002/bjs5.50268. Epub 2020 Mar 19.

Abstract

BACKGROUND

Pancreatoduodenectomy (PD) with portal vein resection (PVR) is a standard operation for pancreatic ductal adenocarcinoma (PDAC) with portal vein (PV) invasion, but positive margin rates remain high. It was hypothesized that regional pancreatoduodenectomy (RPD), in which soft tissue around the PV is resected en bloc, could enhance oncological clearance and survival.

METHODS

This retrospective study included consecutive patients who underwent PD with PVR between January 2005 and December 2016 in a single high-volume centre. In standard PD (SPD) with PVR, the PV was skeletonized and the surrounding soft tissue dissected. In RPD, the retropancreatic segment of the PV was resected en bloc with its surrounding soft tissue. The extent of lymphadenectomy was similar between the procedures.

RESULTS

A total of 268 patients were included (177 SPD, 91 RPD). Tumours were more often resectable in patients undergoing SPD (60·5 per cent versus 38 per cent in those having RPD; P = 0·014), and consequently they received neoadjuvant therapy less often (7·9 versus 25 per cent respectively; P < 0·001). R0 resection was achieved in 73 patients (80 per cent) in the RPD group, compared with 117 (66·1 per cent) of those in the SPD group (P = 0·016), although perioperative outcomes were comparable between the groups. Median recurrence-free (RFS) and overall (OS) survival were 17 and 32 months respectively in patients who had RPD, compared with 11 and 21 months in those who had SPD (RFS: P = 0·003; OS: P = 0·004).

CONCLUSION

RPD is as safe and feasible as SPD, and may increase the survival of patients with PDAC with PV invasion.

摘要

背景

胰十二指肠切除术(PD)联合门静脉切除(PVR)是治疗伴有门静脉(PV)侵犯的胰腺导管腺癌(PDAC)的标准手术,但阳性切缘率仍居高不下。有人假设,区域性胰十二指肠切除术(RPD)整块切除 PV 周围软组织,可以增强肿瘤的清除率并提高生存率。

方法

这是一项回顾性研究,纳入了 2005 年 1 月至 2016 年 12 月期间在单一高容量中心接受 PD 联合 PVR 的连续患者。在标准 PD 联合 PVR 中,对 PV 进行骨骼化,并对周围软组织进行解剖。在 RPD 中,整块切除 PV 的胰后段及其周围软组织。两种手术的淋巴结清扫范围相似。

结果

共纳入 268 例患者(177 例 SPD,91 例 RPD)。行 SPD 的患者肿瘤更具可切除性(60.5%对 RPD 组的 38%;P=0.014),因此他们接受新辅助治疗的频率较低(分别为 7.9%和 25%;P<0.001)。RPD 组 73 例(80%)患者达到 R0 切除,而 SPD 组 117 例(66.1%)患者达到 R0 切除(P=0.016),尽管两组围手术期结局相当。RPD 组患者无复发生存(RFS)和总生存(OS)中位数分别为 17 个月和 32 个月,而 SPD 组患者分别为 11 个月和 21 个月(RFS:P=0.003;OS:P=0.004)。

结论

RPD 与 SPD 一样安全可行,可能会提高伴有 PV 侵犯的 PDAC 患者的生存率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验